Drupal.behaviors.print = function(context) {window.print();window.close();}>
In Countersuit, Santaris Aims to Invalidate Isis Gapmer Patents
December 15, 2011
In Countersuit, Santaris Aims to Invalidate Isis Gapmer Patents
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Isis Opposes Santaris Bid to Throw out Patent-Infringement Suit
March 29, 2012 / Gene Silencing News
Court Denies Santaris Bid to End Isis Patent-Infringement Case
September 27, 2012 / Gene Silencing News
Arbiter Settles Santaris-Exiqon LNA Dispute; Each Firm Claims Victory
October 13, 2011 / Gene Silencing News
EPO Rejects Mirrx Bid to Reinstate Patent Proceedings Ahead of Ruling on Suit with Santaris
July 21, 2011 / Gene Silencing News
Despite Limitations, Gymnotic Delivery of Antisense Oligos Offers Benefits over Transfection
June 23, 2011 / Gene Silencing News